Whole Exome Sequencing in Coloboma/Microphthalmia: Identification of Novel and Recurrent Variants in Seven Genes.
Patricia HaugSamuel KollerJordi MaggiElena LangSilke FeilAgnès WlodarczykLuzy BährKatharina SteindlMarianne RohrbachChristina Gerth-KahlertWolfgang BergerPublished in: Genes (2021)
Coloboma and microphthalmia (C/M) are related congenital eye malformations, which can cause significant visual impairment. Molecular diagnosis is challenging as the genes associated to date with C/M account for only a small percentage of cases. Overall, the genetic cause remains unknown in up to 80% of patients. High throughput DNA sequencing technologies, including whole-exome sequencing (WES), are therefore a useful and efficient tool for genetic screening and identification of new mutations and novel genes in C/M. In this study, we analyzed the DNA of 19 patients with C/M from 15 unrelated families using singleton WES and data analysis for 307 genes of interest. We identified seven novel and one recurrent potentially disease-causing variants in CRIM1, CHD7, FAT1, PTCH1, PUF60, BRPF1, and TGFB2 in 47% of our families, three of which occurred de novo. The detection rate in patients with ocular and extraocular manifestations (67%) was higher than in patients with an isolated ocular phenotype (46%). Our study highlights the significant genetic heterogeneity in C/M cohorts and emphasizes the diagnostic power of WES for the screening of patients and families with C/M.
Keyphrases
- genome wide
- end stage renal disease
- bioinformatics analysis
- copy number
- ejection fraction
- high throughput
- chronic kidney disease
- data analysis
- peritoneal dialysis
- prognostic factors
- single cell
- genome wide identification
- dna methylation
- cell free
- circulating tumor
- patient reported outcomes
- physical activity
- transcription factor
- fatty acid
- patient reported
- optic nerve